Vektor Medical, Inc. was founded by a close-knit team of engineers, scientists, doctors, and entrepreneurs with the shared belief that harnessing the power of computational modeling could vastly improve cardiac arrhythmia care.
Our mission is to deliver an innovative, non-invasive arrhythmia mapping solution that’s capable of helping physicians provide personalized solutions for the treatment of complex cardiac rhythm disorders. We aim to accomplish this through superior leadership, cutting-edge technology, ongoing physician education and outreach, and patient service.
Mike Monko is a recognized senior executive with over 20 years of leadership and management experience in the life science, biotech, and diagnostics industries. Prior to his leadership at Vektor, Mike served as an executive at Life Technologies, Serologicals, and Sequenom.
Rob Krummen has spent 15 years leading and advising corporations, nonprofits, institutions of higher education, and state entities. Before he joined Vektor, Rob served as managing attorney at Chesapeake Energy Corporation. He is also a former partner at Vorys, Sater, Seymour and Pease LLP and former deputy solicitor general for the State of Ohio. He earned his JD from Harvard Law School in 2003.
Kalle Marsal is a senior executive with an extensive background in technology systems, enterprise software, and services markets. He served as chief operating officer at Mitek and is a former executive at HP. He earned his MBA/MS at Stanford University.
Dr. David Krummen is a professor of medicine at the University of California San Diego and the director of electrophysiology at the VA San Diego Healthcare System. He is a recognized expert in cardiac arrhythmia research. He invented and performed the world’s first targeted ventricular fibrillation substrate ablation procedure. Dr. Krummen has authored more than 70 papers in the field.
Dr. Chris Villongco has more than a decade of experience in computational modeling of cardiac physiology, including patient-specific modeling. Dr. Villongco is a former post-doctoral fellow and graduate of the bioengineering and medical departments at the University of California San Diego.
Dr. Andrew McCulloch is a distinguished professor of bioengineering and medicine at the University of California San Diego (UCSD). He serves as a principal investigator of both the National Biomedical Computation Resource and the Cardiac Atlas Project. He is also a member of the UCSD Institute of Engineering in Medicine and Qualcomm Institute, and a senior fellow of the San Diego Supercomputer Center.
Dr. Gordon Ho is an assistant professor of medicine at the University of California San Diego. He has more than 10 years of experience in computational modeling, ventricular fibrillation, and atrial fibrillation. Dr. Ho was recently awarded National Institutes of Health and American Heart Association career development grants to study the mechanisms of atrial fibrillation.
